Clozaril (Clozapine): How This Antipsychotic Works, ANC Monitoring, and When Telehealth Helps

Last updated: August 21, 2026

Clozaril (clozapine) is a second-generation (atypical) antipsychotic used for treatment-resistant schizophrenia and for reducing the risk of recurrent suicidal behavior in people with schizophrenia or schizoaffective disorder. It is one of the most effective options when standard antipsychotics have not been enough, and it also carries serious risks that require careful medical supervision: severe neutropenia, seizures, heart inflammation, orthostatic blood-pressure drops, and metabolic changes. This guide explains how clozapine works, labeled dosing patterns, side effects, absolute neutrophil count (ANC) monitoring after the Clozapine REMS program was removed, and where online psychiatry may help versus what still needs in-person lab and specialty care.

See if online depression or mood care may be a fit →

Browse Klarity condition pages →

What is Clozaril (clozapine)?

Clozapine is an atypical antipsychotic. According to MedlinePlus, it is used to treat schizophrenia in certain people by changing the activity of natural substances in the brain. Brand and related products include Clozaril® tablets, Versacloz® oral suspension, Fazaclo® orally disintegrating tablets (ODT), and generic clozapine tablets and ODTs.

NAMI describes clozapine as a second-generation antipsychotic (SGA) that rebalances dopamine and serotonin to improve thinking, mood, and behavior. Forms NAMI lists:

• Oral tablets: common strengths include 25 mg, 50 mg, 100 mg, 200 mg (brand Clozaril® and generics; Clozaril label highlights 25 mg and 100 mg scored tablets)
• Orally disintegrating tablets: strengths such as 12.5 mg, 25 mg, 100 mg, 150 mg, 200 mg
• Versacloz®: oral suspension 50 mg/mL

Clozapine is not a first-line “starter” antipsychotic for most people. Prescribers reserve it for situations where the benefit can justify intensive monitoring and slow titration.

How clozapine works

Clinicians discuss clozapine as blocking dopamine D2 and serotonin 5-HT2A receptors, among other receptor effects. That profile can reduce hallucinations, delusions, and disorganized thinking when other antipsychotics have failed. It still carries class and drug-specific warnings and needs ongoing medical supervision.

MedlinePlus notes that clozapine controls schizophrenia but does not cure it. It may take several weeks or longer before you feel the full benefit. Continue the medicine even when you feel well unless your prescriber changes the plan. Do not stop suddenly without guidance; your clinician will usually taper.

NAMI emphasizes long-term treatment for schizophrenia, daily dosing as prescribed, and contacting the prescriber if more than two days of doses are missed, because the dose may need to be restarted lower.

FDA-labeled uses

Per the DailyMed CLOZARIL (clozapine) tablet prescribing information (label updated June 6, 2025; recent major changes to boxed warning, dosage and administration, and neutropenia warnings 6/2025), Clozaril is an atypical antipsychotic indicated for:

• Treatment-resistant schizophrenia: severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Because of risks of severe neutropenia and seizure, Clozaril should be used only in patients who have failed adequate trials of standard antipsychotics
• Recurrent suicidal behavior: reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior

The FDA Drug Safety Communication (August 27, 2025) describes the same core uses: people severely ill with schizophrenia who remain symptomatic on other medicines, and people with schizophrenia or schizoaffective disorder who have been suicidal and may be at risk for recurrent suicidal behavior.

NAMI notes that clozapine may also be used off-label for psychosis in Parkinson’s disease in selected cases; off-label use requires a documented clinical rationale and is not a substitute for FDA labeling.

Your clinician matches the indication, formulation, titration speed, lab plan, and monitoring to your history. This article is education, not a personal prescription plan.

Typical dosing (label ranges)

Always follow the dose on your prescription. DailyMed dosage and administration highlights for Clozaril include:

• Starting dose: 12.5 mg once daily or twice daily
• Early titration: if well tolerated, increase the total daily dosage in increments of 25 mg to 50 mg per day to a target of about 150 mg to 225 mg twice per day by the end of two weeks
• Later increases: may increase in increments up to 100 mg once or twice weekly
• Maximum: 450 mg twice daily (900 mg/day total)
• Food: administer with or without food

NAMI states clozapine is usually taken 1 or 2 times per day with or without food, with a low start and slow increase over several weeks. Only your clinician can set your dose.

Missed doses matter. MedlinePlus and NAMI both stress that if you miss clozapine for more than 2 days, call your doctor before restarting; the dose often needs to go back down and climb again to lower the risk of orthostasis, seizures, and other restart risks.

How to take clozapine (tablets, ODT, suspension)

From MedlinePlus and NAMI administration guidance:

• Take at about the same time(s) every day
• ODT: use dry hands; peel the foil (do not push the tablet through); place on the tongue to dissolve; swallow with saliva; water is not required. Keep ODTs in original packaging; do not store them loose in a pillbox. Some ODTs contain aspartame (phenylalanine), which matters if you have PKU
• Oral suspension (e.g., Versacloz): shake as directed, use the correct oral syringe size, measure carefully, take right after drawing the dose, rinse the syringe, and do not refrigerate or freeze the suspension
• Do not share your medicine. Keep all lab and clinic appointments your team orders

Boxed warnings and serious risks

DailyMed’s boxed warning for Clozaril covers several life-threatening risks:

• Severe neutropenia: associated with serious and fatal infections. Obtain baseline ANC before starting. Initiation is not recommended if baseline ANC is less than 1500/μL (less than 1000/μL for people with benign ethnic neutropenia / Duffy-null associated neutrophil count). Dosage modifications and testing frequency follow ANC results in the full label
• Orthostatic hypotension, bradycardia, and syncope: dose-related; start at 12.5 mg; titrate gradually; use divided doses
• Seizure: dose-related; titrate gradually; use caution with seizure history or risk factors
• Myocarditis, pericarditis, cardiomyopathy, and mitral valve incompetence: can be fatal; discontinue and obtain cardiac evaluation if findings suggest these reactions
• Increased mortality in elderly patients with dementia-related psychosis: Clozaril is not approved for that use

MedlinePlus patient warnings align with these themes: life-threatening white-cell drops and infection risk, seizures, heart inflammation or pump problems, and low blood pressure or slow heart rate especially at start or dose increases. Call your clinician urgently for fever, sore throat, chills, extreme tiredness, chest pain, trouble breathing, fainting, or seizures.

Other important label warnings include gastrointestinal hypomotility with severe complications (treat constipation promptly), eosinophilia with possible organ involvement, QT prolongation, and metabolic changes (hyperglycemia, diabetes risk, weight, lipids).

ANC monitoring after the Clozapine REMS was removed

For years, U.S. clozapine access ran through a shared Clozapine REMS program that required enrollment of prescribers, pharmacies, and patients and reporting of ANC results before many dispenses. That system often delayed or blocked care.

On February 24, 2025, the FDA announced it no longer expected REMS participation or ANC reporting to the REMS before pharmacies dispense clozapine, while still recommending ANC monitoring per the prescribing information. See the FDA’s Information on Clozapine page and FAQ on the REMS modification.

The FDA later formally removed the Clozapine REMS, effective June 13, 2025. Key points from that safety communication:

• Prescribers, pharmacies, and patients are no longer required to enroll in the REMS or report ANC to a REMS in order for clozapine to be dispensed
• Severe neutropenia risk remains; it is greatest in the first several months but never fully goes away
• Prescribers should continue ANC monitoring at the frequencies in the prescribing information and Medication Guide so neutropenia can be caught early
• Eliminating the REMS is expected to improve access and reduce system burden

NAMI’s February 27, 2025 statement welcomed the FDA’s move to remove burdensome REMS barriers while keeping clozapine available for people with treatment-resistant schizophrenia.

What this means for patients: fewer pharmacy “REMS holds,” not zero medical monitoring. Your team still orders blood work on a schedule, adjusts or pauses therapy if ANC falls, and watches for infection symptoms. Do not assume “REMS is gone” means “no labs.”

Common and serious side effects

NAMI lists common side effects such as increased heart rate, low blood pressure, drowsiness, sedation, dizziness, headache, vertigo, increased salivation (sialorrhea), sweating, visual disturbance, weight gain, constipation, nausea, vomiting, and fever.

MedlinePlus common effects include drowsiness; dizziness or balance trouble; increased salivation; dry mouth; restlessness; and headache. Serious symptoms that need prompt medical contact include severe constipation or abdominal pain, uncontrolled movements, fever with muscle stiffness and confusion (possible neuroleptic malignant syndrome), liver-related symptoms, chest pain or sudden shortness of breath, and swelling or pain in a limb (possible clot).

FDA’s safety communication lists common effects including sleepiness, headache, dizziness, tremor, cardiovascular effects, low blood pressure, fast heartbeat, excess saliva, syncope, dry mouth, sweating, constipation, nausea, vision problems, and fever, and highlights severe neutropenia, blood-pressure/heart-rate problems, seizures, serious heart problems, and dementia-related mortality risk.

Metabolic monitoring (weight, glucose, lipids) is standard for many SGAs, including clozapine. Constipation is not a minor nuisance on this drug; severe GI hypomotility can become a medical emergency.

Drug interactions and lifestyle factors

Clozapine levels can change with other medicines and habits. Always give your full medication and supplement list to your prescriber and pharmacist. Points from MedlinePlus and clinical practice education:

• St. John’s wort may interact; do not start it without clinician approval
• Cigarette smoking can lower clozapine levels (induce metabolism); stopping smoking can raise levels and side effects. Tell your clinician if you start or stop smoking
• Caffeine intake can matter; ask your clinician about large changes in coffee, tea, or energy drinks
• Alcohol can worsen sedation and other side effects
• Other medicines that affect heart rhythm, blood pressure, seizure threshold, or sedation may need extra caution

DailyMed also points clinicians to full interaction tables, renal/hepatic dosing notes, and CYP2D6 poor-metabolizer considerations in the complete label.

Pregnancy, breastfeeding, and special populations

NAMI notes that third-trimester antipsychotic exposure can be linked to newborn EPS or withdrawal symptoms (agitation, feeding problems, tone changes, respiratory distress, somnolence, tremor). Breastfeeding needs caution because clozapine passes into breast milk. MedlinePlus advises calling your doctor if you become pregnant on clozapine and discussing plans before conception when possible.

Older adults with dementia-related psychosis face higher death risk on antipsychotics; clozapine is not approved for that use.

When telehealth is enough, and when it is not

Online psychiatry can support parts of the journey: second opinions on whether treatment-resistant schizophrenia criteria are met, education about monitoring, medication review for interactions, coordination with local labs, and follow-up once a stable regimen and monitoring plan exist. Klarity’s network includes 2,000+ licensed providers who can discuss mental health options that may fit your state and clinical picture.

Clozapine itself is different from many telehealth-friendly antidepressants or first-line antipsychotics:

• Initiation and early titration often need tight coordination for ANC draws, vital-sign checks, and rapid response to fever or cardiac symptoms
• REMS enrollment is no longer required for dispense, but label-directed ANC monitoring and clinical judgment still are
• Missed-dose restarts, high-dose therapy, suspected myocarditis, severe constipation, or unstable psychosis may need urgent in-person or higher-acuity care
• Telehealth does not replace emergency services for chest pain, severe infection signs, seizure, or suicidal crisis

If you are exploring care for mood symptoms, depression, or related conditions online, start with a clinical evaluation rather than requesting a specific high-risk medicine by name. See online depression treatment and related condition pages to learn how visits work.

Check whether online mental health care may be an option →

Related medications and further reading

Other atypical antipsychotics people compare when discussing schizophrenia or bipolar care include:

• Abilify (aripiprazole)
• Vraylar (cariprazine)
• Seroquel (quetiapine)
• Latuda (lurasidone)
• Zyprexa (olanzapine)
• Risperdal (risperidone)
• Geodon (ziprasidone)
• Invega (paliperidone)
• Fanapt (iloperidone)
• Saphris (asenapine)
• Rexulti (brexpiprazole)
• Caplyta (lumateperone)

None of these is a simple swap for clozapine in treatment-resistant schizophrenia. Choice depends on diagnosis, prior trials, side-effect history, labs, and shared decision-making.

Insurance and access notes

Coverage for clozapine, lab monitoring, and psychiatry visits may vary by plan, pharmacy benefit, prior authorization rules, and state. Some plans still apply quantity limits or specialty pharmacy pathways even after REMS removal. Verify benefits before you assume a specific brand, generic, or lab schedule is covered. Klarity content uses cautious language on purpose: no article can promise that your insurance will pay for a given drug or visit.

Disclaimer: This page is for general education only. It is not medical advice, a diagnosis, or a guarantee of treatment, prescribing, or insurance coverage. Always confirm details with your clinician and your plan. If you are in crisis or thinking about harming yourself, call or text 988 (U.S. Suicide & Crisis Lifeline), call 911, or go to the nearest emergency department.

Frequently asked questions

Is clozapine the same as Clozaril?

Clozaril is a brand name for clozapine tablets. Generic clozapine and other brands (such as Versacloz suspension and certain ODT products) contain the same active ingredient but may differ in form, strength options, and inactive ingredients.

Do I still need blood tests if the REMS is gone?

Yes, in the sense that FDA and product labeling still emphasize ANC monitoring to catch severe neutropenia early. What changed is the mandatory REMS enrollment and reporting system for dispenses, not the clinical need to watch white-cell counts, especially early in treatment.

Can a telehealth doctor start clozapine online?

Some parts of evaluation and follow-up can happen by video, but starting and maintaining clozapine usually depends on reliable local lab access, a monitoring plan, and a team ready for urgent symptoms. Many people need hybrid care. Do not expect a one-click online start without labs and a documented treatment-resistant indication.

How long does clozapine take to work?

MedlinePlus says it may take several weeks or longer to feel the full benefit. Schizophrenia treatment is typically long-term. Stay on the prescribed schedule unless your clinician changes it.

What should I do if I miss more than two days?

Contact your prescriber before restarting. Labels and patient education warn that missed multi-day gaps often require a lower restart dose because of orthostasis, seizure, and other risks.

Bottom line

Clozapine (Clozaril and related products) remains a cornerstone option for treatment-resistant schizophrenia and for reducing recurrent suicidal behavior risk in selected patients with schizophrenia or schizoaffective disorder. The 2025 removal of the Clozapine REMS lowered administrative barriers, but neutropenia risk, ANC monitoring, slow titration, and cardiac/GI vigilance are still central to safe use. Telehealth can support education, coordination, and ongoing mental health care; it does not erase the need for labs and urgent in-person response when serious warning signs appear.

If you want to explore online mental health evaluation for depression, mood, or related concerns with Klarity’s 2,000+ licensed providers, start here:

See if online care may be a fit →

Browse conditions →